<html>
<head>
<meta content="text/html; charset=windows-1252"
http-equiv="Content-Type">
</head>
<body bgcolor="#FFFFFF" text="#000000">
<p>Hi Michael,</p>
<p>I think this would be a great call to reschedule. I know you do
the best you can, but we do to. With so little notice of the
topic, many members may have conflicts. Also it is necessary to
have time to review documents ahead of time. You and Sophia put
time into preparing the documents (tx you), but we should be
allowed to have time to review them... and we all have very busy
lives so a few days, at a minimum, is key. Have you circulated the
draft? <br>
</p>
<p>On this important, well-discussed and not-in-agreement topic, I
strongly recommend <i>and request </i>a bump of a week or to to
give everyone a chance to review materials ahead of time and
prepare based on these materials. But a day's notice on this topic
-- at a height of the US business day time when people already
many conflicts with this timing -- on this topic, with virtually
no notice, is hardly fair timing. <br>
</p>
<p>Best, Kathy<br>
</p>
<br>
<div class="moz-cite-prefix">On 1/31/2018 12:58 AM, Michael Flemming
wrote:<br>
</div>
<blockquote
cite="mid:CAAE6pKFnz5Y=6HjyNiKErFriFaXM5+=45cxnb+GpFtnoo1_bZQ@mail.gmail.com"
type="cite">
<div dir="ltr">Dear All,
<div><br>
</div>
<div>Please note that this week we have a call scheduled for
WT2. I know that a lot of individuals are traveling for a
number of sessions and events being held throughout this week.
Unfortunately, we are unable to reschedule the 1 February 2018
15 UTC call, so I invite individuals to comment and provide
feedback over the mailing list. The topic for this week will
be <b>Closed Generics</b>. </div>
<div><br>
</div>
<div>As Sophia and I have highlighted in our emails over the
last several weeks, we have been putting together documents
that summarize, analyze, and offer paths forward for our
topics in WT2. Already we have looked at the Registry
Agreement, Registrant Protections, Reserved Names, and the
Applicant Terms and Conditions. Documents have been circulated
and shared with the group, but we have had very little
feedback outside of our biweekly calls. I highly encourage
participants to provide feedback on what we have highlighted
and are proposing in these documents. The goal for these
documents is to present to the overall WG what we are
recommending as WT2.</div>
<div><br>
</div>
<div>I hope those of you that can join us will do so this week
to engage in our discussion on Closed Generics.</div>
<div><br>
</div>
<div>Sincerely,</div>
<div><br>
</div>
<div>Michael Flemming & Sophia Feng</div>
<div>WT2 Co-Chairs</div>
</div>
<br>
<fieldset class="mimeAttachmentHeader"></fieldset>
<br>
<pre wrap="">_______________________________________________
Gnso-newgtld-wg-wt2 mailing list
<a class="moz-txt-link-abbreviated" href="mailto:Gnso-newgtld-wg-wt2@icann.org">Gnso-newgtld-wg-wt2@icann.org</a>
<a class="moz-txt-link-freetext" href="https://mm.icann.org/mailman/listinfo/gnso-newgtld-wg-wt2">https://mm.icann.org/mailman/listinfo/gnso-newgtld-wg-wt2</a></pre>
</blockquote>
<br>
</body>
</html>